Sughrue Mion, PLLC
Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
A heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing the inventive heteroaryl-pyrasole compounds or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
Green Cross Corporation
C C C A C C C C C
C07D C07D C07D A61P C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Kwang-Woo Jong Yup Myung Eun Jeong Min Ji-Hyun Suk Ho Hee Jeong Min-ah Kwang-Seop Suk Youn Chong-Hwan Jonathan Jinhwa Sung-han
Ahn Kim Jung Kim Park Lee Seo Kim Song Kang Chang Lee Lee